Please find below biographies of our international speakers.
Andreas Arendtsen Rostved
Rigshospitalet, Copenhagen, Denmark
Andreas Arendtsen Rostved
Rigshospitalet, Copenhagen, Denmark
Andreas Arendtsen Rostved, MD, PhD, is a transplant surgeon and researcher focusing on immunology in liver transplantation, with particular emphasis on donor-specific HLA antibodies and graft outcomes.
03 Feb, 11:00 | Transplant Immunology & Donor Specific Antibodies
Miriam Cortes Cerisuelo
King’s College Hospital, London, United Kingdom
Miriam Cortes Cerisuelo
King’s College Hospital, London, United Kingdom
Dr. Miriam Cortes Cerisuelo is a consultant surgeon in adult and paediatric liver transplantation, and pediatric HPB in King’s College Hospital since April 2016; In 2002, she graduated in Medicine from Barcelona University, and completed general surgery residency in Hospital La Fe in Valencia, Spain. She completed her doctorate in metabonomics, as a useful tool to predict liver functionality after liver transplant, in the University of Valencia and then was appointed as a clinical liver transplant fellow in King’s College Hospital between 2012-2015.
Later, she was awarded with an MRC Centre for Transplantation/Emory Bridging Fellowship which funded one-year post-doctoral fellowship in one of the leading Immunology Transplant Centres in the United States where she worked under the direction of Dr Mandy Ford, scientific director in “Emory Transplant Centre”. On September 2023, she became a board member of ELITA; and in March 2024, she was appointed as clinical lead in adult and paediatric liver transplant surgery at King’s College Hospital.
Her main clinical interests are focused on paediatric liver and small bowel transplantation, and patterns of portal hypertension in young adults requiring a liver transplant, as well as machine perfusion and DCD liver transplantation. Other research interests are the impact of machine perfusion on alloimmune responses and developing more accurate scoring systems of early allograft function after transplantation.
03 Feb, 13:30 | Liver transplantation in very young infants
03 Feb, 09:00 | Carl-Gustav Groth lecture, sponsored by Sandoz: State-of-the-art: Pediatric Liver Transplantation
Valérie McLin
Hôpital des Enfants, Geneva, Switzerland
Valérie McLin
Hôpital des Enfants, Geneva, Switzerland
Dr Valérie McLin is the Medical Lead of the Swiss Pediatric Liver Center in Geneva, Switzerland and also the Principal Investigator of the International Registry of Congenital Portosystemic Shunts.
She has a long-standing interest in characterizing the unique features of the neurocognitive manifestations of juvenile-onset liver disease and portosystemic bypass both in animals models and human subjects.
Recently, she has been expanding her research into portosystemic disease in general, to include pulmonary vascular liver disease, renal involvement, and endocrine manifestations.
03 Feb, 13:30 | Congenital portosystemic shunts (CPSS)
03 Feb, 16:45 | Spectrum of neurocognitive Involvement in Pediatric Liver disease and Portosystemic Shunting
Faouzi Saliba
Paul Brousse Hospital, Paris, France
Faouzi Saliba
Paul Brousse Hospital, Paris, France
Faouzi Saliba is associate Professor of Hepatology and Gastroenterology at the University of Paris Saclay, France. He’s in charge of the Liver Intensive Care Unit and the Endoscopy Unit at the Hepato-Biliary and Liver Transplant Center of Henri Bismuth at Paul Brousse Hospital (Assistance Publique -Hôpitaux de Paris).
He’s a member of the council of the International Liver Transplantation Society, and a Board member of the EASL-Chronic Liver failure (CLIF) Consortium group. He’s also a member of several national and international societies.
He has conducted and coordinated several international and national clinical trials in the fields of transplantation, immunology, hepatology, artificial liver support, and infectious diseases, and has published more than 275 original papers in peer-reviewed journals, in addition to many other journal articles, book chapters and textbooks.
03 Feb, 11:00 | Indications and Obstacles for mTOR inhibitors in Liver Transplantation
Rajani Sharma
Columbia University Irving Medical Center, New York City, USA
Rajani Sharma
Columbia University Irving Medical Center, New York City, USA
Rajani Sharma, MD is an Assistant Professor of Medicine at the Columbia University College of Physicians and Surgeons and an attending transplant hepatologist at the Center for Liver Disease and Transplantation at Columbia University Irving Medical Center in New York City. She completed her internal medicine, gastroenterology, and transplant hepatology training at Columbia. In her clinical practice, she cares for both hepatology and liver transplant patients.
Aside from clinical work, her academic focus is medical education. She leads the hepatology and transplant education program for the medicine residents in training, lectures on hepatology in the main medical school clinical course, and has been creating a specialty clerkship for medical students on liver transplantation. She also has a Master’s Degree in Biostatistics from Columbia University’s Mailman School of Public Health, and has performed population-based outcomes research on autoimmune hepatitis patients.
She has very recently moved to Stockholm, Sweden with her family. She is very much looking forward to meeting the hepatology and transplant community in Sweden, and working together with all of you.
03 Feb, 11:00 | Chronic Rejection of the Liver Graft
